SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is actively trending following the launch of its low-cost compounded GLP-1 weight-loss pill, which has triggered immediate legal and regulatory scrutiny from the FDA and Novo Nordisk. The community is sharply divided between those predicting a severe downturn due to perceived 'piracy' and 'unethical' practices, and others who see the significant sell-off as an 'oversold' opportunity against 'Big Pharma' and anticipate a bounce.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing a massive surge following news of a $250 million extended Equity Line of Credit, which the community believes secures funding until 2028 and prevents future dilution or reverse splits. Many anticipate a significant short squeeze and multi-day run, drawing comparisons to its past parabolic rallies.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending with significant upward momentum following its forecast for a first-ever adjusted operating profit in Q4 2025 and the imminent 100 millionth battery swap milestone, fueling community excitement that its unique Battery-as-a-Service model has proven viable and warrants a major revaluation.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as the Justice Department's antitrust probe into Netflix's rival bid for Warner Bros. Discovery leads the community to believe PSKY's all-cash offer now has a clearer path, further bolstered by the success of its recent exclusive UFC event on Paramount+.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is trending as the community actively profits from its inverse performance against MicroStrategy, fueled by discussions around MSTR's perceived vulnerability to Bitcoin fluctuations and ongoing dilution.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is trending as investors react to its FDA Breakthrough Device Designation for the CellFX nsPFA Cardiac Surgery System and promising clinical data from its nPulse cardiac catheter, driving optimism around its 'game-changing' technology and potential for significant upside, with community discussions also highlighting high insider ownership and low float dynamics.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending due to robust VEVYE prescription growth, boosted by new formulary wins and an expanding sales force, with the community actively anticipating a short squeeze amid reaffirmed guidance and a solid pipeline.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is soaring following strong earnings and a record backlog, driven significantly by its unexpected positioning as a major beneficiary of AI-driven data center power demand. The community is actively debating its current valuation, with some celebrating its industrial leadership while others caution it appears overbought.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending following a significant $26 billion write-down related to resetting its electric vehicle strategy and suspending its 2026 dividend, yet simultaneously announced a $13 billion U.S. investment to boost traditional brands like Jeep and Ram. This mixed news has sparked divided community sentiment, with many questioning product quality and the EV pivot, while others see a deep value opportunity in the strategic recalibration and focus on customer demand.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx Holdings Corp. is trending after a dramatic post-earnings sell-off, which the community is largely viewing as an overreaction to robust Q2 results, raised guidance, and recent positive developments like FDA Breakthrough Device designation and a key recommendation from the American Academy of Pediatrics. Despite the sharp drop, many investors are seizing the opportunity to buy the dip, anticipating a rebound and highlighting the company's long-term potential in genomics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
